XML 47 R30.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ Deficit (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Equity [Abstract] |
Schedule of Stock Based Compensation Expense Recognized for Officer and Director Arrangements | The following table summarizes stock-based compensation expense recognized for all officer and director arrangements for the years ended December 31, 2025 and 2024: Schedule of Stock Based Compensation Expense Recognized for Officer and Director Arrangements
|  | December 31, 2025 |  |  | December 31, 2024 |
Chief Executive Officer |  | $ | - |  |  | $ | 3,800,000 |
Chief Financial Officer |  |  | 479,077 |  |  |  | 2,148,681 |
Board of Directors |  |  | 460,913 |  |  |  | 132,025 |
Director of HR and Legal Services |  |  | - |  |  |  | 672,000 |
Total |  | $ | 939,990 |  |  | $ | 6,752,706 |
Stock based compensation expense |  | $ | 939,990 |  |  | $ | 6,752,706 |
Schedule of Non-vested Shares Related Parties | The following is a summary of the Company’s non-vested shares at December 31, 2025 and 2024. Schedule of Non-vested Shares Related Parties
|  |  |  |  | Weighted Average |
Non-Vested Shares |  | Number of Shares |  |  | Grant Date Fair Value |
Balance - December 31, 2023 |  |  | 695,000 |  |  | $ | 5.24 |
Granted |  |  | 644,640 |  |  |  | 7.60 |
Vested |  |  | (1,000,000 | ) |  |  | 6.55 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - December 31, 2024 |  | $ | 339,640 |  |  |  | 5.03 |
Granted |  |  | 150,000 |  |  |  | 3.16 |
Vested |  |  | (288,880 | ) |  |  | 4.77 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - December 31, 2025 |  |  | 200,760 |  |  | $ | 4.00 |
Unrecognized Compensation |  | $ | 507,262 |  |  |  |  |
Weighted average period (years) |  |  | 2.57 |  |  |  |  |
Schedule of Stock Granted | The following is a detail of the common stock granted, which is subject to the vesting provisions noted above at December 31, 2025 and 2024, respectively. Schedule of Stock Granted
|  | CEO |  |  | CFO |  |  | Directors |  |  | Director of Human Resources/Legal |  |  | Total |
Balance - December 31, 2023 |  |  | - |  |  |  | 600,000 |  |  |  | 95,000 |  |  |  | - |  |  |  | 695,000 |
Granted |  |  | 500,000 |  |  |  | - |  |  |  | 44,640 |  |  |  | 100,000 |  |  |  | 644,640 |
Vested |  |  | (500,000 | ) |  |  | (400,000 | ) |  |  | - |  |  |  | (100,000 | ) |  |  | (1,000,000 | )
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Balance - December 31, 2024 |  |  | - |  |  |  | 200,000 |  |  |  | 139,640 |  |  |  | - |  |  |  | 339,640 |
Granted |  |  | - |  |  |  | - |  |  |  | 150,000 |  |  |  | - |  |  |  | 150,000 |
Vested |  |  | - |  |  |  | (200,000 | ) |  |  | (88,880 | )* |  |  | - |  |  |  | (288,880 | )
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Balance - December 31, 2025 |  |  | - |  |  |  | - |  |  |  | 200,760 |  |  |  | - |  |  |  | 200,760 |
Unrecognized Compensation |  | $ | - |  |  | $ | - |  |  | $ | 507,262 |  |  | $ | - |  |  | $ | 507,262 |
Weighted average period (years) |  |  | - |  |  |  | - |  |  |  | 2.57 |  |  |  | - |  |  |  | 2.57 |
Schedule of Stock Option Transactions | Stock option transactions for the years ended December 31, 2025 and 2024 are summarized as follows: Schedule of Stock Option Transactions
|  |  |  |  |  |  |  | Weighted |  |  |  |  |  |  |
|  |  |  |  |  |  |  | Average |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  | Remaining |  |  |  |  |  | Average |
|  |  |  |  | Average |  |  | Contractual |  |  | Aggregate |  |  | Grant |
Stock Options |  | Number of Options |  |  | Exercise Price |  |  | Term (Years) |  |  | Intrinsic Value |  |  | Date Fair Value |
Outstanding - December 31, 2023 |  |  | 121,276 |  |  | $ | 7.79 |  |  |  | 6.47 |  |  | $ | - |  |  |  |  |
Vested and Exercisable - December 31, 2023 |  |  | 116,174 |  |  | $ | 7.43 |  |  |  | 6.61 |  |  | $ | - |  |  |  |  |
Unvested and non-exercisable - December 31, 2023 |  |  | 5,101 |  |  | $ | 16.00 |  |  |  | 3.16 |  |  | $ | - |  |  |  |  |
Granted |  |  | 1,054,603 |  |  | $ | 1.78 |  |  |  |  |  |  |  |  |  |  | $ | 1.52 |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (9,798 | ) |  | $ | 6.45 |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2024 |  |  | 1,166,081 |  |  | $ | 2.37 |  |  |  | 6.85 |  |  | $ | - |  |  |  |  |
Vested and Exercisable - December 31, 2024 |  |  | 1,166,081 |  |  | $ | 2.37 |  |  |  | 6.85 |  |  | $ | - |  |  |  |  |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |
Granted |  |  | 1,144,116 |  |  | $ | 1.75 |  |  |  |  |  |  |  |  |  |  | $ | 1.49 |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (17,253 | ) |  | $ | 1.78 |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2025 |  |  | 2,292,944 |  |  | $ | 2.06 |  |  |  | 6.43 |  |  | $ | - |  |  |  |  |
Vested and Exercisable - December 31, 2025 |  |  | 2,292,944 |  |  | $ | 2.06 |  |  |  | 6.43 |  |  | $ | - |  |  |  |  |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |
Schedule of Fair Value of Stock Options | The fair value of these stock options was determined using the Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of Stock Options
Expected term |  |  | 7 years |
Expected volatility |  |  | 103 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 3.88 | %
The fair value of these stock options was determined using a Black-Scholes option pricing model with the following inputs:
Expected term |  |  | 7 years |
Expected volatility |  |  | 104 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 4.48 | %
Schedule of Stock Based Compensation Expense | Stock-based compensation expense related to stock options for the years ended December 31, 2025 and 2024 was as follows: Schedule of Stock Based Compensation Expense
Years Ended December 31, |
2025 |  |  | 2024 |
$ | 1,701,735 |  |  | $ | 1,609,193 |
Schedule of Warrants Activity | Warrant activity for the years ended December 31, 2025 and 2024 are summarized as follows: Schedule of Warrants Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  |  |  |  | Average |  |  |  |
|  |  |  |  | Weighted |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Average |  |  | Contractual |  |  | Intrinsic |
Warrants |  | Warrants |  |  | Exercise Price |  |  | Term (Years) |  |  | Value |
Outstanding - December 31, 2023 |  |  | 5,574,253 |  |  | $ | 4.81 |  |  |  | 0.86 |  |  | $ | 9,348,348 |
Vested and Exercisable - December 31, 2023 |  |  | 5,574,253 |  |  | $ | 4.81 |  |  |  | 0.86 |  |  | $ | 9,348,348 |
Unvested - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |
Exercised |  |  | (1,953,308 | ) |  | $ | 4.73 |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (3,524,945 | ) |  | $ | 4.86 |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2024 |  |  | 96,000 |  |  | $ | 4.73 |  |  |  | 0.37 |  |  | $ | - |
Vested and Exercisable - December 31, 2024 |  |  | 96,000 |  |  | $ | 4.73 |  |  |  | 0.37 |  |  | $ | - |
Unvested and non-exercisable - December 31, 2024 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | 730,000 |  |  | $ | 5.86 |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (96,000 | ) |  | $ | 4.73 |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2025 |  |  | 730,000 |  |  | $ | 5.86 |  |  |  | 4.30 |  |  | $ | - |
Vested and Exercisable - December 31, 2025 |  |  | 730,000 |  |  | $ | 5.86 |  |  |  | 4.30 |  |  | $ | - |
Unvested and non-exercisable - December 31, 2025 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |

X
- Definition Tabular disclosure of stock based compensation expense recognized for officer and director arrangements. + References No definition available. + Details
Name: | SURG_ScheduleOfStockBasedCompensationExpenseRecognizedForOfficerAndDirectorArrangementsTableTextBlock
Namespace Prefix: | SURG_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Stock Based Compensation Expense [Table Text Block] + References No definition available. + Details
Name: | SURG_ScheduleOfStockBasedCompensationExpenseTableTextBlock
Namespace Prefix: | SURG_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Stock Granted [Table Text Block] + References No definition available. + Details
Name: | SURG_ScheduleOfStockGrantedTableTextBlock
Namespace Prefix: | SURG_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration